InSight shareholder offers to buy firm
A shareholder group that owns one-third of InSight Health Services has offered to buy the rest of the company, the Newport Beach, CA, imaging services firm reported this month. InSight has formed a special committee to evaluate the proposal, which
A shareholder group that owns one-third of InSight Health Services has offered to buy the rest of the company, the Newport Beach, CA, imaging services firm reported this month. InSight has formed a special committee to evaluate the proposal, which InSight executives said was unsolicited.
The proposal was made by investment firms the Carlyle Group and the Halifax Group, which together own 33% of the company. The investor group intends to buy the rest of InSight for $10 a share and merge it with an affiliated company, InSight management said. In addition to forming the special committee, InSight has retained an investment banking firm to consider the bid.
In other InSight news, the company reported financial results for its third quarter (end-March). InSight reported revenues of $40.8 million, up 44% compared with $28.4 million in the same period last year. Much of the increase was due to acquisitions InSight made last year, such as its purchase of Signal Medical Systems (SCAN 4/1/98).
On the profit side, InSight reported net income of $525,000, compared with $1.9 million in the third quarter of 1998. The drop was due to an increase in interest expense of $2.2 million, the company said.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
